The Philippine FDA warned the public against the use of Ivermectin to treat COVID-19.
The Philippine Food and Drug Administration (FDA) warned the public against the use of Ivermectin in order to treat COVID-19.
Manila Bulletin reported that the FDA had warned the public against the use of Ivermectin veterinary medicine as a treatment for COVID-19.
The Food and Drug Administration said in an advisory that Ivermectin veterinary medicine was only approved for use in animals through oral and intravenous preparations.
According to the Food and Drug Administration, the medicine was being used to prevent heartworm disease and to treat external and internal parasites in certain animal species.
“The drug is an important part of a parasite control program for some animal species and should only be administered according to its approved indication, or as prescribed by a duly licensed veterinarian. The public is warned against taking animal drugs, as the FDA has only evaluated their safety and efficacy in the particular species for which they are labeled. Using these products in humans can cause serious harm. Animal drugs are often highly concentrated and can be highly toxic to humans,” the FDA said.
READ ALSO: FDA Cancels Inspection Trip To Russia Due To This Reason
The Food and Drug Administration noted that the registered Ivermectin products in the Philippines for human use were “in topical formulations under prescription use only.” This means it can only be applied to the human skin and wasn’t being taken orally.
Also, the Food and Drug Administration said that Ivermectin wasn’t approved “for treatment of any viral infection”.
Moreover, the Food and Drug Administration said that any use of Ivermectin veterinary products for the prevention or treatment of coronavirus disease (COVID-19) should be avoided as the benefits and safety for this purpose had not been established.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
